comparemela.com

Latest Breaking News On - Aerovate therapeutics company profile - Page 1 : comparemela.com

Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Up 3.6%

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shot up 3.6% during mid-day trading on Thursday . The company traded as high as $24.05 and last traded at $23.86. 59,742 shares traded hands during trading, a decline of 62% from the average session volume of 159,164 shares. The stock had previously closed at $23.02. Wall […]

United-states
Switzerland
Swiss
Timothyp-noyes
Marinus-verwijs
Aerovate-therapeutics-inc
Wells-fargo-company
Jefferies-financial-group
Ikarian-capital
Securities-exchange-commission
Aerovate-therapeutics-company-profile
Vanguard-group-inc

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Up 16.5% in May

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,190,000 shares, an increase of 16.5% from the April 30th total of 1,880,000 shares. Based on an average daily trading volume, of 167,500 shares, the short-interest […]

Switzerland
Alps
Switzerland-general
United-states
Swiss
Benjamint-dake
Georgea-eldridge
Aerovate-therapeutics-inc
Eventide-asset-management
Alps-advisors-inc
Securities-exchange-commission

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Insider Sells $84,320.00 in Stock

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Hunter Gillies sold 4,000 shares of the stock in a transaction on Friday, May 17th. The stock was sold at an average price of $21.08, for a total value of $84,320.00. Following the sale, the insider now owns 5,602 shares in the company, valued at approximately […]

United-states
Hunter-gillies
Jefferies-financial-group
Aerovate-therapeutics-company-profile
Wells-fargo-company
Alps-advisors-inc
Securities-exchange-commission
Aerovate-therapeutics-inc
Nasdaq
Vanguard-group-inc
Eventide-asset-management
Ikarian-capital

Wedbush Reiterates "Outperform" Rating for Aerovate Therapeutics (NASDAQ:AVTE)

Wedbush reaffirmed their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $41.00 price target on the stock. Wedbush also issued estimates for Aerovate Therapeutics’ Q2 2024 earnings at ($0.71) EPS, Q3 2024 earnings at ($0.66) EPS, Q4 2024 earnings […]

Alps
Switzerland-general
Switzerland
United-states
Swiss
Marinus-verwijs
Timothyp-noyes
Ikarian-capital
Alps-advisors-inc
Jefferies-financial-group
Aerovate-therapeutics-inc
Wells-fargo-company

Aerovate Therapeutics (NASDAQ:AVTE) Sees Large Volume Increase

Aerovate Therapeutics (NASDAQ:AVTE) Sees Large Volume Increase
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states
Alps
Switzerland-general
Switzerland
Swiss
Benjamint-dake
Aerovate-therapeutics-inc
Eventide-asset-management
Wells-fargo-company
Swiss-national-bank
Aerovate-therapeutics-company-profile
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.